The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice
Open accessAbstract
Administration of staphylococcal enterotoxin B (SEB) to BALB/c mice was found to induce a cytokine release syndrome hallmarked by weight loss and hypoglycemia. A neutralizing monoclonal antibody against gamma interferon (IFN-gamma) given before SEB counteracted weight loss and prevented hypoglycemia. This protective effect of anti-IFN-gamma antibody was associated with decreased IFN-gamma levels in serum; tumor necrosis factor (TNF) and interleukin-6 (IL-6) levels remained unchanged. A monoclonal anti-IL-6 antibody, known for its ability to cause accumulation of biologically active IL-6 in the circulation, did not modify SEB-induced body weight loss or hypoglycemia. Levels of TNF, IFN-gamma, and IL-6 in serum were all more elevated in anti-IL-6-treated mice than in corresponding SEB-challenged control mice. In D-galactosamine-sensitized mice, SEB-induced weight loss but not hypoglycemia was more severe, resulting mostly in death within 24 h. Higher levels of biologically active TNF and IFN-gamma in serum were noted in these mice than in mice receiving SEB only. In D-galactosamine-sensitized mice, anti-IFN-gamma antibody did prevent hypoglycemia but failed to reduce the severity of the syndrome. Again, TNF levels in anti-IFN-gamma-treated mice remained unchanged. Pretreatment with anti-IL-6 antibody temporarily attenuated SEB-induced hypoglycemia in sensitized mice. Thus, at 6 h post-SEB injection, anti-IL-6-treated mice were less hypoglycemic than corresponding controls. However, at 24 h, hypoglycemia was significantly aggravated. Concomitantly, IL-6 levels were dramatically increased. Neither anti-IFN-gamma nor anti-IL-6 antibody treatment modulated mortality levels in D-galactosamine-sensitized mice. The data obtained with anti-IFN-gamma antibody clearly indicate that endogenous IFN-gamma is instrumental in bringing about hypoglycemia and body weight loss in mice exposed to SEB but also that hypoglycemia is not a crucial determinant of mortality in D-galactosamine-sensitized mice. The data obtained with anti-IL-6 antibody indicate that endogenous IL-6 is involved in regulating the levels of TNF and IFN-gamma in serum.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice treated with a monoclonal anti-IL-6 antibody display increased levels of TNF (34), suggesting that IL-6 may in fact counter regulate TNF levels.”
From Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle (2006) · cites this paper as [34]
In the citing paper
“and levels of TNF-α are markedly elevated in anti-IL-6-treated mice and in IL-6-deficient knockout mice [67, 68], indicating that circulating IL-6 is involved in the regulation of TNF-α levels.”
From Exercise as a Mean to Control Low‐Grade Systemic Inflammation (2008) · cites this paper as [67]
Citations
Cites
1 retracted
Starnes, H. F., Pearce, M. K., Tewari, A., Yim, J. H., Zou, J. C., & Abrams, J. S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4185 · Cited by 322
RetractedEspevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,256
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
Tracey, K. J., He, W., Manogue, K. R., Fong, Y., HESSE, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., & Cerami, A. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.3.1211 · Cited by 730
Snick, J. V., Cayphas, S., Vink, A., Uyttenhove, C., Coulie, P. G., Rubira, M. R., & Simpson, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9679 · Cited by 679
Tumors secreting human TNF/cachectin induce cachexia in mice
Oliff, A. I., Defeo-Jones, D., BOYER, M. E., Martinez, D., KIEFER, D. M., Vuocolo, G. A., Wolfe, A. L., & Socher, S. H. (1987) · Cell · doi:10.1016/0092-8674(87)90028-6 · Cited by 640
Miethke, T., Wahl, C., Heeg, K., Echtenacher, B., Krammer, P. H., & Wagner, H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.91 · Cited by 574
Lehmann, V., Freudenberg, M. A., & Galanos, C. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.165.3.657 · Cited by 547
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
Klein, B., Wijdenes, J., Zhang, X., Jourdan, M., Boiron, J.-M., Brochier, J., Liautard, J., Merlin, M., Clement, C., & Morel-Fournier, B. (1991) · Blood · doi:10.1182/blood.v78.5.1198.1198 · Cited by 417
The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells.
Marrack, P., Blackman, M. A., Kushnir, E., & Kappler, J. W. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.2.455 · Cited by 341
Heremans, H., Damme, J. V., Dillen, C., Dijkmans, R., & Billiau, A. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.6.1853 · Cited by 214
Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock
Bean, A. G. D., Freiberg, R. A., Andrade, S., Menon, S., & Zlotnik, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.11.4937-4939.1993 · Cited by 162
Severe cachexia in mice inoculated with interferon‐γ‐producing tumor cells
Matthys, P., Dukmans, R., Proost, P., Damme, J. V., Heremans, H., Sobis, H., & Billiau, A. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490115 · Cited by 157
Stiles, B. G., Bavari, S., Krakauer, T., & Ulrich, R. G. (1993) · Infection and Immunity · doi:10.1128/iai.61.12.5333-5338.1993 · Cited by 141
Nagaki, M., Muto, Y., Ohnishi, H., Yasuda, S., Sano, K., Naito, T., Maeda, T., Yamada, T., & Moriwaki, H. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90604-1 · Cited by 104
Lu, Z., Brochier, J., Wijdenes, J., Brailly, H., Bataille, R., & Klein, B. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221110 · Cited by 102
Heremans, H., Dillen, C., Put, W., Damme, J. V., & Billiau, A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220932 · Cited by 101
Strassmann, G., Fong, M., Windsor, S., & Neta, R. (1993) · Cytokine · doi:10.1016/1043-4666(93)90058-d · Cited by 77
Matthys, P., Dillen, C., Proost, P., Heremans, H., Damme, J. V., & Billiau, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230924 · Cited by 69
Linomide, a novel immunomodulator that prevents death in four models of septic shock
Gonzalo, J. A., González-Garcı́a, A., Kalland, T., Hedlund, G., Martínez‐A, C., & Kroemer, G. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230949 · Cited by 64
Gonzalo, J. A., Baixerás, E., González-Garcı́a, A., George‐Chandy, A., van Rooijen, N., Martı́nez, C., & Kroemer, G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1597 · Cited by 55
Truyens, C., ANGELO‐BARRIOS, A., Torrico, F., Damme, J. V., Heremans, H., & Carlier, Y. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.692-696.1994 · Cited by 48
Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia
Vogel, S. N., Henricson, B. E., & Neta, R. (1991) · Infection and Immunity · doi:10.1128/iai.59.7.2494-2498.1991 · Cited by 46
Franks, A. K., Kujawa, K. I., & Yaffe, L. J. (1991) · Infection and Immunity · doi:10.1128/iai.59.8.2609-2614.1991 · Cited by 39
Martens, E., Dillen, C., Put, W., Heremans, H., van Damme, J., & Billiau, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230846 · Cited by 38
Vogel, S. N., & Havell, E. A. (1990) · Infection and Immunity · doi:10.1128/iai.58.7.2397-2400.1990 · Cited by 29
Interferon induced in mouse spleen cells by Staphylococcus aureus
Heremans, H., LEY, M. D., Billiau, A., & Somer, P. D. (1982) · Cellular Immunology · doi:10.1016/0008-8749(82)90269-6 · Cited by 18
Cited by
Sorted by citations
The anti-inflammatory effect of exercise
Petersen, A. M. W., & Pedersen, B. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00164.2004 · Cited by 3,100
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388
IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans
Steensberg, A., Fischer, C. P., Keller, C., Møller, K., & Pedersen, B. K. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00074.2003 · Cited by 1,135
Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles
FEBBRAIO, M. A., & PEDERSEN, B. K. (2002) · The FASEB Journal · doi:10.1096/fj.01-0876rev · Cited by 875
Interleukin-6 in acute exercise and training: what is the biological relevance?
Fischer, C. P. (2026) · PubMed · doi:10.22029/eir.2006.1620 · Cited by 817
Metadata
- Authors
- Matthys, P., Mitera, T., Heremans, H., Van Damme, J., & Billiau, A.
- Affiliations
- Rega Institute for Medical Research (BE)
- Laboratory of Immunobiology, Rega Institute, University of Leuven, Belgium.
- ORCID
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 1995-04
- Volume
- 63
- Issue
- 4
- Pages
- 1158-1164
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC173128
- OpenAlex
- W1905898110
- Cited by
- 134
- References
- 26
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 1 · 2020: 3 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 8 · 2013: 5 · 2012: 6
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Infection and Immunity (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- staphylococcal enterotoxin B, cytokine release syndrome, interferon-gamma, interleukin-6, TNF-α, anti-IFN-gamma monoclonal antibody, anti-IL-6 monoclonal antibody, D-galactosamine sensitization, hypoglycemia, weight loss, cytokine production, mortality, endotoxin
- MeSH terms
- Animals, Body Weight, Diarrhea, Enterotoxins, Galactosamine, Hypoglycemia, Immunologic Techniques, Interferon-gamma, Mice, Inbred BALB C, Time Factors, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Superantigens, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
